Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Rocket Mortgage Is at a Risky Phase in the Cycle

Higher interest rates and defaults will hurt RKT stock, so the next entry point should be below book value to create a margin of safety.

Genius Brands Has a Shot at Making It Big If It Spends Cash Wisely

Genus Brands has a shot at making it big if it spends its cash wisely. GNUS stock depends on how profitable the studio can make its deals.

Why Innovative Ankr Risks Getting J.P. Morgan-ed

While ANKR is undergirded by an extremely promising blockchain network, the sour investment market won’t cooperate.

Stem Stock Is a Buy on Its Latest Pullback

Stem is set to benefit from very strong macro trends, making STEM stock extremely attractive at this point.

Will Lucid Motors Make Churchill Capital Stock a Boom or a Bust?

With its reverse merger nearly completed, retail investors will get to see if CCIV stock, will deliver on the potential that they see.  

GameStop Isn’t Going to Do Nearly as Well as These 3 Promising Stocks

GameStop has a market cap of $14.8 billion. GME stock might be popular with retail investors but these three alternatives are better buys.  

ChargePoint Holdings Stock Has a ‘Filling Station’ Problem

What electric car owners need are stations where they can fill-up in a half-hour, get some coffee and be entertained. That's a problem for ChargePoint.

Don’t Just Look At the Price Tag on Penn National Gaming Stock

Although PENN stock has shed significant market value since mid-March, you’ll want to carefully assess this trade before deciding on your move.

Still Living in the Past, IBM Remains Behind the Tech Ball

IBM hasn't won a title in 25 years and its latest moves under executive chair Virginia Rometty show it's not going to now.

Canopy Growth Is Worth Owning Despite Congress Dithering

The move to legalize cannabis at the federal level proceeds at a snail’s pace. That doesn’t mean Canopy Growth and CGC stock is dead money. 

5 Top Value Stocks Reviewed: 3 to Buy, 2 to Skip

Value stocks that are trading at a lower price and destined to rise can bring strong returns. But not every discounted stock is a buy.

7 Gold and Silver Stocks to Buy as the Fear Trade Silently Heats Up

Since the markets usually follow a cyclical pattern, it may be time to avoid stretched growth names and consider gold and silver stocks.

5 Important Stocks to Watch Right Now… and Why

Some stocks are so influential that they demand to be on every investor's watchlist. These are market moving companies that impact us all.

Paysafe Looks Like the Right Stock at the Wrong Time

PSFE stock should stand out on the long list of SPAC stocks. But so far, the investment community at large doesn’t share the enthusiasm.

Editas Stock Isn’t Worth Buying This Early Into Treatment Development

EDIT stock is part of a pioneering movement in CRISPR gene editing, but there's no way to know whether the company will succeed long term.

Virgin Galactic Takes Off, Literally More Than Figuratively

While SPCE stock is more than a meme stock, led by veteran CEO, it's still a new industry that will be transforming rapidly in coming years.

The Next Generation of Billionaires Will Be Made in This Industry

I firmly believe that the next generation of billionaires will be made in space. The economic opportunities are that big. Not surprisingly, I think there are dozens upon dozens of 10X investment opportunities hiding in plain sight in this industry.

Churchill Capital Stock Is Likely to Rally in the Short-Term, Sink in the Longer Term

CCIV stock will move a lot in the next few months. The owners of the stock should pay close attention to these dates.

Zomedica Is Still Working Out How to Sell Truforma. Can Investors Afford to Wait?

Zomedica came public too soon, but it does have enough cash to see a finish line. The question is, can ZOM stock investors afford to wait?